Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.
Colombo C, Alicandro G, Daccó V, Gagliano V, Morlacchi LC, Casciaro R, Pisi G, Francalanci M, Badolato R, Bignamini E, Messore B, Lucanto MC, Leonetti G, Maschio M, Cipolli M; Italian Cystic Fibrosis Society (SIFC) Study Group for COVID-19. Colombo C, et al. Among authors: francalanci m. PLoS One. 2021 May 13;16(5):e0251527. doi: 10.1371/journal.pone.0251527. eCollection 2021. PLoS One. 2021. PMID: 33984027 Free PMC article.
Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.
Bruzzese E, Raia V, Ruberto E, Scotto R, Giannattasio A, Bruzzese D, Cavicchi MC, Francalanci M, Colombo C, Faelli N, Daccò V, Magazzù G, Costa S, Lucidi V, Majo F, Guarino A. Bruzzese E, et al. Among authors: francalanci m. J Cyst Fibros. 2018 May;17(3):375-382. doi: 10.1016/j.jcf.2017.10.014. Epub 2017 Nov 8. J Cyst Fibros. 2018. PMID: 29128317 Free article. Clinical Trial.
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function.
Salvatore D, Terlizzi V, Francalanci M, Taccetti G, Messore B, Biglia C, Pisi G, Calderazzo MA, Caloiero M, Pizzamiglio G, Majo F, Cresta F, Leonetti G, De Venuto D. Salvatore D, et al. Among authors: francalanci m. Respir Med. 2020 Sep;171:106073. doi: 10.1016/j.rmed.2020.106073. Epub 2020 Jul 3. Respir Med. 2020. PMID: 32846335 Free article.
[Italian Cystic Fibrosis Registry (ICFR). Report 2017-2018].
Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC. Campagna G, et al. Epidemiol Prev. 2021 May-Jun;45(3 Suppl 1):1-37. doi: 10.19191/EP21.3.S1.050. Epidemiol Prev. 2021. PMID: 34132083 Free article. Italian.
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
Colombo C, Cipolli M, Daccò V, Medino P, Alghisi F, Ambroni M, Badolato R, Battistini F, Bignamini E, Casciaro R, Ciciriello F, Collura M, Comello I, Francalanci M, Ficili F, Folino A, Leonardi S, Leonetti G, Lucanto MC, Lucca F, Maschio M, Mencarini V, Messore B, Pisi G, Pizzamiglio G, Poli P, Raia V, Riberi L, Ros M, Rotolo N, Sepe A, Taccetti G, Vitullo P, Alicandro G. Colombo C, et al. Among authors: francalanci m. Infection. 2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7. Infection. 2022. PMID: 34874541 Free PMC article.
[Italian Cystic Fibrosis Registry (ICFR). Report 2019-2020].
Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC. Campagna G, et al. Epidemiol Prev. 2022 Jul-Aug;46(4 Suppl 2):1-38. doi: 10.19191/EP22.4S2.060. Epidemiol Prev. 2022. PMID: 36102313 Free article. Italian.
41 results